SOLID FORMS COMPRISING (-) O-DESMETHYLVENLAFAXINE AND USES THEREOF
    7.
    发明公开
    SOLID FORMS COMPRISING (-) O-DESMETHYLVENLAFAXINE AND USES THEREOF 有权
    FESTE FORMEN MIT( - ) - O-DESMETHYLVENLAFAXIN UND VERWENDUNGEN DAVON

    公开(公告)号:EP2114863A2

    公开(公告)日:2009-11-11

    申请号:EP08725968.5

    申请日:2008-02-21

    申请人: Sepracor Inc.

    摘要: Solid forms comprising a compound useful in the treatment, prevention and management of various conditions and diseases are provided herein. In particular, the invention provides solid forms comprising (-)-O-desmethylvenlafaxine, including salts thereof, having utility for the treatment, prevention and management of conditions and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders.

    摘要翻译: 本文提供了包含可用于治疗,预防和治疗各种病症和疾病的化合物的固体形式。 特别地,本发明提供了包含( - ) - O-去甲基文拉法辛(包括其盐)的固体形式,其可用于治疗,预防和治疗病症和病症,包括但不限于情感障碍如抑郁症,双相和躁狂症 失调,注意力缺陷障碍,多动症的注意力缺陷障碍,帕金森病,癫痫,脑功能障碍,肥胖和体重增加,失禁,痴呆和相关疾病。

    METHOD OF RESOLVING AMLODIPINE RACEMATE
    8.
    发明公开
    METHOD OF RESOLVING AMLODIPINE RACEMATE 审中-公开
    解聚阿米地平杀鼠剂的方法

    公开(公告)号:EP1448527A1

    公开(公告)日:2004-08-25

    申请号:EP02802193.9

    申请日:2002-10-23

    申请人: Sepracor, Inc.

    IPC分类号: C07D211/90

    CPC分类号: C07D211/90

    摘要: The invention relates to methods of resolving racemic amlodipine into enantiomerically enriched compositions by precipation with tartaric acid in the presence of a non-aqueous solvent, such as N,N'-dimethylacetamide. The molar ratio of tartaric acid:amlodipine is preferably less than 0.25:1.0 greater than 0.75:1.0.

    摘要翻译: 本发明涉及通过在非水溶剂如N,N'-二甲基乙酰胺存在下用酒石酸沉淀将外消旋氨氯地平拆分成对映体富集的组合物的方法。 酒石酸:氨氯地平的摩尔比优选小于0.25:1.0,大于0.75:1.0。